Intra-Cellular Therapies Inc.

(ITCI) Trade

By |

Profile

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Contact Information

Website: www.intracellulartherapies.com
Email: ir@intracellulartherapies.com
Main Phone: +1 646 440-9333
Address: 430 East 29th Street
City / Town: New York
Country: USA
Postal Code: 10016

Issuer Information

Exchange: NGS
CEO: Sharon Mates
Employees: 73
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

Contact Information

Website: www.intracellulartherapies.com
Email: ir@intracellulartherapies.com
Main Phone: +1 646 440-9333
Address: 430 East 29th Street
City / Town: New York
Country: USA
Postal Code: 10016

Issuer Information

Exchange: NGS
CEO: Sharon Mates
Employees: 73
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 11.42 $ 0.23 (2.06%)
Last Price 11.42 Change $ 0.23 Change % 2.06 Tick N/A
Bid 10.00 Bid Size 100.00 Ask 20.00 Ask Size 400.00
Open 11.19 High 11.60 Low 11.14 Prev Close 11.19
Last Trade Volume 990,982 52 Wk Hi 23.62 52 Wk Low 10.09
Market Cap 629.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 55,134,625.00 EPS (TTM) -2.82 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 46
Number of Buys 4 31
Number of Sells 0 15
Net Activity 2266 481271
Last 10 Buys Shares
Christopher Alafi 1,000
Moshe H. Alafi 1,000
Christopher Alafi 1,000
Moshe H. Alafi 1,000
Christopher Alafi 1,000
Moshe H. Alafi 1,000
Christopher Alafi 1,000
Christopher Alafi 1,000
Christopher Alafi 1,000
Christopher Alafi 1,000
Last 10 Sell Shares
Lawrence J. Hineline 1,000
Lawrence J. Hineline 1,000
Michael I. Halstead 1,000
Kimberly E. Vanover 1,000
Sharon Mates 1,000
Sharon Mates 1,000
Kimberly E. Vanover 1,000
Lawrence J. Hineline 1,000
Michael I. Halstead 1,000
Lawrence J. Hineline 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 33 33 33 33
Low Target Price Estimate 25 25 25 25
Mean Target Price Estimate 28.88 28.88 28.88 28.88
Standard Deviation 3.18 3.18 3.18 3.18
Date of Most Recent Estimate 05/25/18 05/25/18 05/22/18 05/25/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 8 9 9
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.11 1.11 1.1 1.1